共 50 条
TAFRO syndrome was effectively treated with an inexpensive novel scheme: A case report
被引:0
作者:
Meng, Shan
[1
]
Liu, Hailing
[1
]
Zhang, Wanggang
[1
]
He, Aili
[1
]
Sun, Honghong
[2
]
Zhang, Ru
[3
]
Chen, Xiaoli
[4
]
Chen, Yinxia
[1
,5
]
机构:
[1] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Hematol, Xian, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 2, Med Imaging Dept, Xian, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Neurol, Xian, Peoples R China
[4] Xi An Jiao Tong Univ, Affiliated Hosp 2, Pathol Dept, Xian, Peoples R China
[5] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Hematol, West 5 Rd 157, Xian, Shaanxi, Peoples R China
来源:
CLINICAL CASE REPORTS
|
2023年
/
11卷
/
02期
关键词:
Castleman disease;
hematology;
immunosuppressive agents;
oncology;
MULTICENTRIC CASTLEMANS-DISEASE;
INTERLEUKIN-6;
RITUXIMAB;
D O I:
10.1002/ccr3.6183
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
A man diagnosed as TAFRO syndrome was successfully responded to a novel immunosuppressive regimen containing methylprednisolone and mycophenolate mofetil. Blood cells firstly recovered, followed by the general situation and complete recover 1 month later, highlighting the danger of TAFRO syndrome and the importance of immunosuppressive agents in reversing pathological course.
引用
收藏
页数:5
相关论文